Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Adamas Pharmaceuticals Inc

TRADE

NASDAQ: ADMSHealthcare / Drugs - Generic / USA
22.43-0.41-1.80%Vol 628 7301Y Perf 59.99%
Aug 17th, 2018 16:00
BID22.21 ASK22.41
Open22.76 Previous Close22.84
Pre-Market- After-Trading22.40
 - -%  -0.03 -0.13%
Target Price
51.25 
Analyst Rating
Strong Buy 1.00
Potencial %
128.49 
Finscreener Ranking
★★★     49.71
Insiders Trans % 3/6/12M
-100/-100/-100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-100/-100/-100 
Growth Ranking
★★     43.69
Insiders Shares Cnt. % 3/6/12M
-100/-100/-100 
Income Ranking
 —    -
Market Cap (mil)610 
Earnings Rating
Price Range Ratio 52wk %
28.46 
Earnings Date

Today's Price Range

22.0522.99

 

52wk Range

13.8544.00

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Month
-16.15%
3 Months
-30.09%
6 Months
-32.37%
1 Year
59.99%
3 Years
3.96%
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
ADMS22.43-0.4100-1.80
AAPL217.584.26002.00
GOOG1 200.96-5.5300-0.46
MSFT107.58-0.0600-0.06
XOM78.260.26000.33
WFC58.860.20000.34
JNJ134.471.99001.50
FB173.80-0.9000-0.52
GE12.300.00000.00
JPM114.770.00000.00
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 9.50
Current Ratio 9.90
Long Term Debt to Total Capital 0.44
Total Debt to Equity 0.78
Interest Coverage -7.90
Leverage Ratio 1.90
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin98.70
EBIT Margin-1 024.70
EBITDA Margin-1 012.00
Pre-tax Profit Margin-5 873.80
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 4.41
PS Ratios 58.77
Price to Cash Flow 23.20
Price to Free Cash Flow -6.40
Cash Flow Per Share -3.96
Price to Tangible Book4.41
Book Value per Share5.24
Enterprise Value (in ths.)536 398
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-27.42
ROE last 12 Months -98.74
Return on Assets (5Y Avg) -12.55
ROA last 12 Months -57.10
Return on Capital (5Y Avg) -1.24
ROC last 12 Months -56.58
Return on invested Capital Q -11.31
Return on invested Capital Y-42.74
Assets Turnover0.00
Receivables Turnover3.10
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)10 687
Revenue per Share 0.39
Revenue Growth 3 Years -31.61
Revenue Growth 5 Years -53.66
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q02 2018-1.41-1.2610.64
Q01 2018-1.38-1.352.17
Q04 2017-1.15-1.27-10.43
Q03 2017-1.03-1.04-0.97
Q02 2017-0.85-0.93-9.41
Q01 2017-0.72-0.720.00
Q04 2016-0.82-0.6817.07
Q03 2016-0.85-0.6622.35
Earnings Per EndEstimateRevision %Trend
6/2018 QR-1.44-8.27Negative
9/2018 QR-1.48-5.71Negative
12/2018 FY-5.79-4.70Negative
12/2019 FY-4.01-34.56Negative
Next Report Date2nd Aug 2018
Estimated EPS Next Report-1.41
Estimates Count5
EPS Growth Next 5 Years %37.70
Volume Overview
Volume628 730
Shares Outstanding (in ths.)27 190
Trades Count2 642
Dollar Volume12 693 248
Avg. Volume800 689
Avg. Weekly Volume534 150
Avg. Monthly Volume709 023
Avg. Quarterly Volume568 952

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

80%20%

Bearish Bullish

55%45%

Bearish Bullish

53%47%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
10 (100.00 %)
9 (100.00 %)
9 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

There are no comments yet.

News

x